Genesis Therapeutics
Matthew Mackenzie is an experienced finance professional currently serving as an FP&A Manager at Parsley Health since March 2022. Previously, Matthew held positions as a Senior Analyst at LPL Financial and as an Analyst at AFT Holdings Inc. Matthew's early career included roles as a Product Manager and Research and Development Chemist at Bio Edge, Inc. Matthew holds an MBA in Finance from the Rady School of Management at the University of California, San Diego, a Master's Degree in Polymer Chemistry from Carnegie Mellon University, and a BS in Biochemistry from California Polytechnic State University-San Luis Obispo.
This person is not in any teams
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.